Literature DB >> 20980360

Need for redesigning pharmacologic research in older individuals. A position statement of the Geriatric Working Group of the Agenzia Italiana del Farmaco (AIFA).

Roberto Bernabei, Achille Caputi, Luigi Di Cioccio, Massimo Fini, Pietro Folino Gallo, Niccolò Marchionni, Walter Marrocco, Daniela Melchiorri, Alessandro Mugelli, Alberto Pilotto, Guido Rasi, Stefano Maria Zuccaro.   

Abstract

Mesh:

Year:  2010        PMID: 20980360     DOI: 10.1093/gerona/glq179

Source DB:  PubMed          Journal:  J Gerontol A Biol Sci Med Sci        ISSN: 1079-5006            Impact factor:   6.053


× No keyword cloud information.
  5 in total

Review 1.  High yield research opportunities in geriatric emergency medicine: prehospital care, delirium, adverse drug events, and falls.

Authors:  Christopher R Carpenter; Manish N Shah; Fredric M Hustey; Kennon Heard; Lowell W Gerson; Douglas K Miller
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2011-04-17       Impact factor: 6.053

2.  Prevalence and Risk Factors Associated with Use of QT-Prolonging Drugs in Hospitalized Older People.

Authors:  C Franchi; I Ardoino; R Rossio; A Nobili; E M Biganzoli; A Marengoni; M Marcucci; L Pasina; M Tettamanti; S Corrao; P M Mannucci
Journal:  Drugs Aging       Date:  2016-01       Impact factor: 3.923

3.  Predictors of thyroid hormone initiation in older adults: results from the cardiovascular health study.

Authors:  Lily L Somwaru; Alice M Arnold; Anne R Cappola
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2011-05-31       Impact factor: 6.053

4.  Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study.

Authors:  Marco Bertolotti; Carlotta Franchi; Marco B L Rocchi; Andrea Miceli; M Vittoria Libbra; Alessandro Nobili; Giulia Lancellotti; Lucia Carulli; Chiara Mussi
Journal:  Drugs Aging       Date:  2017-04       Impact factor: 3.923

Review 5.  Multimorbidity and polypharmacy in the elderly: lessons from REPOSI.

Authors:  Pier Mannuccio Mannucci; Alessandro Nobili
Journal:  Intern Emerg Med       Date:  2014-08-28       Impact factor: 3.397

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.